Legend Biotech Net Income 2019-2020 | LEGN

Legend Biotech net income from 2019 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Legend Biotech Annual Net Income
(Millions of US $)
2020 $-303
2019 $-133
2018 $-3
Legend Biotech Quarterly Net Income
(Millions of US $)
2020-12-31 $-58
2020-09-30 $-67
2020-06-30 $-135
2020-03-31 $-44
2019-12-31 $-64
2019-09-30 $-28
2019-06-30 $-29
2019-03-31 $-12
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.703B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.385B 15.58
Bristol Myers Squibb (BMY) United States $143.929B 9.98
CSL (CSLLY) Australia $98.424B 0.00
Gilead Sciences (GILD) United States $83.778B 8.88
Moderna (MRNA) United States $64.284B 128.40
Vertex Pharmaceuticals (VRTX) United States $55.180B 22.73
Illumina (ILMN) United States $55.055B 79.39
Regeneron Pharmaceuticals (REGN) United States $53.425B 15.21
Biogen (BIIB) United States $40.967B 9.38
BioNTech SE (BNTX) Germany $40.576B 1050.00
Alexion Pharmaceuticals (ALXN) United States $37.542B 14.26
BeiGene (BGNE) Cayman Islands $28.794B 0.00
Seagen (SGEN) United States $24.694B 42.65
Genmab (GMAB) Denmark $24.412B 28.63
Genmab (GNMSF) Denmark $22.137B 5.09
Horizon Therapeutics Public (HZNP) Ireland $20.202B 25.83
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.806B 45.69
Exact Sciences (EXAS) United States $18.529B 0.00
Incyte (INCY) United States $18.102B 35.79
CureVac (CVAC) Germany $17.561B 0.00
Bio-Techne Corp (TECH) United States $15.946B 84.04
Alnylam Pharmaceuticals (ALNY) United States $15.528B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.365B 131.02
Zai Lab (ZLAB) China $13.877B 0.00
Guardant Health (GH) United States $13.612B 0.00
ARGENX SE-ADR (ARGX) Netherlands $13.251B 0.00
Novavax (NVAX) United States $12.782B 0.00
QIAGEN (QGEN) Netherlands $10.877B 19.32
Repligen (RGEN) United States $10.169B 91.69
CRISPR Therapeutics AG (CRSP) Switzerland $8.171B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.808B 0.00
AbCellera Biologics (ABCL) $7.776B 0.00
Mirati Therapeutics (MRTX) United States $7.739B 0.00
Acceleron Pharma (XLRN) United States $7.395B 0.00
Exelixis (EXEL) United States $7.270B 116.10
Fate Therapeutics (FATE) United States $7.198B 0.00
Ascendis Pharma (ASND) Denmark $7.143B 0.00
Halozyme Therapeutics (HALO) United States $6.834B 52.99
Denali Therapeutics (DNLI) United States $6.541B 234.65
Sarepta Therapeutics (SRPT) United States $5.952B 0.00
Blueprint Medicines (BPMC) United States $5.436B 16.55
Vir Biotechnology (VIR) United States $5.325B 0.00
Adaptive Biotechnologies (ADPT) United States $5.135B 0.00
Twist Bioscience (TWST) United States $5.074B 0.00
Galapagos (GLPG) Belgium $4.989B 0.00
NeoGenomics (NEO) United States $4.923B 841.20
SWEDISH ORP BIO (BIOVF) Sweden $4.570B 16.56
Intellia Therapeutics (NTLA) United States $4.529B 0.00
Certara (CERT) United States $4.495B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.392B 0.00
Beam Therapeutics (BEAM) United States $4.385B 0.00
I-Mab (IMAB) China $4.245B 0.00
Arena Pharmaceuticals (ARNA) United States $3.828B 0.00
Apellis Pharmaceuticals (APLS) United States $3.741B 0.00
Alkermes (ALKS) Ireland $3.532B 0.00
SpringWorks Therapeutics (SWTX) United States $3.491B 0.00
Reata Pharmaceuticals (RETA) United States $3.377B 0.00
Insmed (INSM) United States $3.356B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.356B 0.00
Emergent Biosolutions (EBS) United States $3.261B 6.49
Berkeley Lights (BLI) United States $3.176B 0.00
Arvinas (ARVN) United States $3.094B 0.00
MorphoSys AG (MOR) Germany $2.906B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.819B 39.85
Intra-Cellular Therapies (ITCI) United States $2.715B 0.00
Amicus Therapeutics (FOLD) United States $2.554B 0.00
ALX Oncology Holdings (ALXO) United States $2.526B 0.00
Vericel (VCEL) United States $2.461B 663.75
Seer (SEER) $2.449B 0.00
Global Blood Therapeutics (GBT) United States $2.380B 0.00
Editas Medicine (EDIT) United States $2.321B 0.00
Instil Bio (TIL) United States $2.314B 0.00
Arcus Biosciences (RCUS) United States $2.139B 0.00
Heska (HSKA) United States $2.115B 922.95
Ligand Pharmaceuticals (LGND) United States $2.106B 35.23
Myriad Genetics (MYGN) United States $2.070B 0.00
NGM Biopharmaceuticals (NGM) United States $2.059B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.043B 0.00
Seres Therapeutics (MCRB) United States $2.015B 0.00
Sorrento Therapeutics (SRNE) United States $2.009B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.002B 0.00
Bluebird Bio (BLUE) United States $2.001B 0.00
Revance Therapeutics (RVNC) United States $1.998B 0.00
PHARMA MAR SA (PHMMF) Spain $1.879B 0.00
Kymera Therapeutics (KYMR) United States $1.847B 0.00
Atea Pharmaceuticals (AVIR) United States $1.822B 0.00
Ocugen (OCGN) United States $1.803B 0.00
Morphic Holding (MORF) United States $1.793B 0.00
Amarin (AMRN) Ireland $1.786B 0.00
Genetron Holdings (GTH) China $1.734B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.711B 0.00
Cytokinetics (CYTK) United States $1.672B 0.00
PureTech Health (PRTC) United States $1.624B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.559B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.558B 0.00
BioAtla (BCAB) United States $1.532B 0.00
UniQure (QURE) Netherlands $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.496B 0.00
Bionano Genomics (BNGO) United States $1.480B 0.00
REGENXBIO (RGNX) United States $1.474B 0.00
C4 Therapeutics (CCCC) United States $1.434B 0.00
Travere Therapeutics (TVTX) United States $1.420B 0.00
Castle Biosciences (CSTL) United States $1.409B 0.00
Precigen (PGEN) United States $1.371B 0.00
Zymeworks (ZYME) Canada $1.361B 0.00
Inovio Pharmaceuticals (INO) United States $1.356B 0.00
Alector (ALEC) United States $1.354B 0.00
Zealand Pharma (ZEAL) Denmark $1.342B 0.00
Shattuck Labs (STTK) United States $1.337B 0.00
Codexis (CDXS) United States $1.278B 0.00
Keros Therapeutics (KROS) United States $1.265B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.248B 0.00
Protagonist Therapeutics (PTGX) United States $1.231B 0.00
Northwest Biotherapeutics (NWBO) United States $1.219B 0.00
Avid Bioservices (CDMO) United States $1.215B 0.00
Nurix Therapeutics (NRIX) United States $1.214B 0.00
Repare Therapeutics (RPTX) Canada $1.197B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.193B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Pliant Therapeutics (PLRX) United States $1.138B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.123B 0.00
MiMedx (MDXG) United States $1.088B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.079B 0.00
Coherus BioSciences (CHRS) United States $1.060B 0.00
Celldex Therapeutics (CLDX) United States $1.053B 0.00
Mersana Therapeutics (MRSN) United States $1.030B 0.00
Scholar Rock Holding (SRRK) United States $1.018B 0.00
Dynavax Technologies (DVAX) United States $1.017B 0.00
MannKind (MNKD) United States $1.016B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.973B 30.72
Affimed (AFMD) Germany $0.953B 0.00
Prothena (PRTA) Ireland $0.947B 0.00
Mesoblast (MESO) Australia $0.917B 0.00
Curis (CRIS) United States $0.914B 0.00
Sutro Biopharma (STRO) United States $0.854B 0.00
Nkarta (NKTX) United States $0.852B 0.00
Bolt Biotherapeutics (BOLT) United States $0.849B 0.00
G1 THERAPEUTICS (GTHX) United States $0.823B 0.00
Avidity Biosciences (RNA) United States $0.820B 0.00
Pharming Group (PHAR) Netherlands $0.808B 0.00
Cel-Sci (CVM) United States $0.805B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.794B 0.00
Merus (MRUS) Netherlands $0.778B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.762B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
Prometheus Biosciences (RXDX) United States $0.744B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.743B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.737B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.734B 0.00
Cellectis S.A (CLLS) France $0.706B 0.00
AnaptysBio (ANAB) United States $0.700B 0.00
Epizyme (EPZM) United States $0.694B 0.00
VBI Vaccines (VBIV) United States $0.689B 0.00
DBV Technologies S.A (DBVT) France $0.660B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.648B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.644B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.643B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Inhibrx (INBX) United States $0.636B 0.00
Kadmon Holdings (KDMN) United States $0.629B 0.00
Agenus (AGEN) United States $0.627B 0.00
IDEAYA Biosciences (IDYA) United States $0.625B 0.00
Cara Therapeutics (CARA) United States $0.623B 155.50
MeiraGTx Holdings (MGTX) United States $0.596B 0.00
Clovis Oncology (CLVS) United States $0.593B 0.00
Anika Therapeutics (ANIK) United States $0.586B 0.00
ChromaDex (CDXC) United States $0.583B 0.00
ALBIREO PHARMA (ALBO) United States $0.579B 0.00
Starpharma Holdings (SPHRY) Australia $0.573B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.564B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.557B 0.00
Inventiva S.A (IVA) France $0.557B 0.00
Adagene (ADAG) China $0.548B 0.00
CytomX Therapeutics (CTMX) United States $0.530B 0.00
RAPT THERAPTICS (RAPT) United States $0.521B 0.00
XBiotech (XBIT) United States $0.511B 0.00
Compugen (CGEN) Israel $0.509B 0.00
Verastem (VSTM) United States $0.489B 0.00
Precision BioSciences (DTIL) United States $0.481B 0.00
Neoleukin Therapeutics (NLTX) United States $0.475B 0.00
Clene (CLNN) United States $0.474B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.457B 0.00
Adicet Bio (ACET) United States $0.451B 0.00
SESEN BIO, INC (SESN) United States $0.444B 0.00
AC Immune SA (ACIU) Switzerland $0.439B 0.00
ANI Pharmaceuticals (ANIP) United States $0.433B 12.07
Forte Biosciences (FBRX) United States $0.432B 0.00
Geron (GERN) United States $0.427B 0.00
Angion Biomedica (ANGN) United States $0.422B 0.00
Amryt Pharma (AMYT) United Kingdom $0.404B 0.00
Seelos Therapeutics (SEEL) United States $0.404B 0.00
Codiak BioSciences (CDAK) United States $0.402B 0.00
Athenex (ATNX) United States $0.400B 0.00
Gritstone Oncology (GRTS) United States $0.400B 0.00
HOOKIPA Pharma (HOOK) United States $0.395B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
BeyondSpring (BYSI) United States $0.389B 0.00
UROGEN PHARMA (URGN) United States $0.377B 0.00
Spero Therapeutics (SPRO) United States $0.376B 0.00
Opthea (OPT) Australia $0.375B 0.00
Oncobiologics (OTLK) United States $0.373B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.373B 0.00
Fortress Biotech (FBIO) United States $0.372B 0.00
AquaBounty Technologies (AQB) United States $0.368B 0.00
Adverum Biotechnologies (ADVM) United States $0.361B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.357B 0.00
XOMA (XOMA) United States $0.352B 164.53
Frequency Therapeutics (FREQ) United States $0.350B 0.00
Fulcrum Therapeutics (FULC) United States $0.346B 0.00
Athersys (ATHX) United States $0.344B 0.00
Syros Pharmaceuticals (SYRS) United States $0.342B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.341B 0.00
Kala Pharmaceuticals (KALA) United States $0.340B 0.00
Cardiff Oncology (CRDF) United States $0.338B 0.00
Selecta Biosciences (SELB) United States $0.337B 0.00
Theratechnologies (THTX) Canada $0.335B 0.00
Cue Biopharma (CUE) United States $0.332B 0.00
SQZ Biotechnologies (SQZ) United States $0.325B 0.00
BioDelivery Sciences (BDSI) United States $0.320B 12.70
Cogent Biosciences (COGT) United States $0.315B 0.00
Innate Pharma S.A (IPHA) France $0.312B 0.00
Kaleido Biosciences (KLDO) $0.310B 0.00
CorMedix Inc (CRMD) United States $0.305B 0.00
Talis Biomedical (TLIS) United States $0.299B 0.00
IBio (IBIO) United States $0.298B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.295B 0.00
Bellus Health (BLU) Canada $0.294B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.275B 0.00
Kamada (KMDA) Israel $0.271B 15.59
Arbutus Biopharma (ABUS) United States $0.270B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.267B 0.00
Cerecor (CERC) United States $0.263B 0.00
Trevena (TRVN) United States $0.263B 0.00
OVID THERAPEUTC (OVID) United States $0.235B 0.00
Chiasma (CHMA) United States $0.230B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
NextCure (NXTC) United States $0.217B 0.00
Kindred Biosciences (KIN) United States $0.209B 0.00
Prima BioMed (IMMP) Australia $0.208B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.199B 0.00
Eton Pharmaceuticals (ETON) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
TELA Bio (TELA) United States $0.192B 0.00
VTv Therapeutics (VTVT) United States $0.192B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
Biofrontera AG (BFRA) Germany $0.183B 0.00
Checkpoint Therapeutics (CKPT) United States $0.178B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Nicox SA (NICXF) France $0.170B 0.00
VolitionRX (VNRX) United States $0.169B 0.00
Voyager Therapeutics (VYGR) United States $0.165B 4.61
Strongbridge Biopharma (SBBP) United States $0.163B 0.00
DiaMedica Therapeutics (DMAC) United States $0.161B 0.00
ObsEva SA (OBSV) Switzerland $0.159B 0.00
Applied Genetic Technologies (AGTC) United States $0.159B 0.00
Exicure (XCUR) United States $0.157B 0.00
INmune Bio (INMB) United States $0.156B 0.00
LogicBio Therapeutics (LOGC) United States $0.153B 0.00
Antibe Therapeutics (ATBPF) Canada $0.152B 0.00
Clearside Biomedical (CLSD) United States $0.151B 0.00
Abeona Therapeutics (ABEO) United States $0.151B 0.00
Erytech Pharma SA (ERYP) France $0.146B 0.00
Protalix BioTherapeutics (PLX) Israel $0.144B 0.00
Catalyst Biosciences (CBIO) United States $0.142B 0.00
X4 Pharmaceuticals (XFOR) United States $0.141B 0.00
Liminal BioSciences (LMNL) Canada $0.140B 0.00
Enzo Biochem (ENZ) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.133B 0.00
Palatin Technologies (PTN) United States $0.129B 0.00
Synlogic (SYBX) United States $0.126B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.126B 0.00
Pluristem Therapeutics (PSTI) Israel $0.123B 0.00
Eyenovia (EYEN) United States $0.123B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Galena Biopharma (SLS) United States $0.118B 0.00
ABVC BioPharma (ABVC) United States $0.115B 0.00
Dyadic (DYAI) United States $0.114B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.113B 0.00
Orgenesis (ORGS) United States $0.111B 227.50
Beyond Air (XAIR) United States $0.108B 0.00
Aptevo Therapeutics (APVO) United States $0.106B 0.00
Aytu BioPharma (AYTU) United States $0.105B 0.00
Longeveron (LGVN) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.102B 0.00
Evofem Biosciences (EVFM) United States $0.101B 0.00
Cocrystal Pharma (COCP) United States $0.100B 0.00
Vascular Biogenics (VBLT) Israel $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.098B 0.00
Evogene (EVGN) Israel $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
TRACON Pharmaceuticals (TCON) United States $0.096B 0.00
Leap Therapeutics (LPTX) United States $0.095B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.090B 0.00
Celsion (CLSN) United States $0.090B 0.00
Zosano Pharma (ZSAN) United States $0.087B 0.00
CytRx (CYTR) United States $0.086B 0.00
Cyclerion Therapeutics (CYCN) United States $0.085B 0.00
Cleveland BioLabs (CBLI) United States $0.082B 0.00
Lumos Pharma (LUMO) United States $0.081B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.081B 0.00
Celyad SA (CYAD) Belgium $0.080B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.079B 0.00
Edesa Biotech (EDSA) Canada $0.079B 0.00
AIkido Pharma (AIKI) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Purple Biotech (PPBT) Israel $0.068B 0.00
Alimera Sciences (ALIM) United States $0.064B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Appili Therapeutics (APLIF) Canada $0.063B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.060B 0.00
AEterna Zentaris (AEZS) United States $0.060B 0.00
ATyr Pharma (LIFE) United States $0.059B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.058B 0.00
Advaxis (ADXS) United States $0.058B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Genetic Technologies (GENE) Australia $0.057B 0.00
Windtree Therapeutics (WINT) United States $0.055B 0.00
BioCardia (BCDA) United States $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
ARIDIS PHARMACT (ARDS) United States $0.052B 0.00
Organovo Holdings (ONVO) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Cyclo Therapeutics (CYTH) United States $0.051B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.050B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Timber Pharmaceuticals (TMBR) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 1.08
Happiness Biotech Group (HAPP) China $0.044B 0.00
Invo BioScience (INVO) United States $0.040B 0.00
GeoVax Labs (GOVX) United States $0.040B 0.00
Yumanity Therapeutics (YMTX) United States $0.038B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Vyant Bio (VYNT) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
ThermoGenesis Holdings (THMO) United States $0.030B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.030B 0.00
IMMURON (IMRN) Australia $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
Vallon Pharmaceuticals (VLON) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Benitec Biopharma (BNTC) United States $0.020B 0.00
Palisade Bio (PALI) United States $0.016B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00